Advocacy intelligence hub — real-time data for patient organizations
Johns Hopkins Bloomberg School of Public Health — PHASE2
GlaxoSmithKline — PHASE2
Inventprise Inc. — PHASE1
Eveliqure Biotechnologies GmbH — PHASE2
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd — PHASE3
University of Oxford — PHASE1
LimmaTech Biologics AG — PHASE2
Leiden University Medical Center — PHASE1
Intralytix, Inc. — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Kawsar R Talaat, MD
Johns Hopkins Bloomberg School of Public Health
📍 BALTIMORE, MD
Patricia Martin, PhD
LimmaTech Biologics AG
Dr Odile Launay, MD
Hôpital Cochin - Bâtiment Modulaire, France
Robert Frenck, MD, MD
Children's Hospital Medical Center, Cincinnati
📍 CINCINNATI, OH
Alexander Sulakvelidze, PhD
Intralytix, Inc.
Odile Launay, Prof
Centre d'Investigation Clinique en Vaccinologie Cochin-Pasteur (CIC1417)